Allergies seem to be on the rise. For many, this is anywhere from a minor to a major inconvenience. But for some, allergic reactions can be so severe that they are dangerous or fatal.<\/p>\n
This poses a challenge to people with severe allergy symptoms<\/a>: what if they come into contact with the allergen, despite their best efforts? This can feel a little like crossing the road with blocked ears and a blind-fold.<\/p>\n Dr. Peter Vadas, at St. Michael\u2019s Hospital (Toronto, Canada) has confirmed<\/strong> that an enzyme<\/strong> which reduces the severity<\/strong> of allergic reactions<\/a> in animals is also effective in humans.<\/p>\n The PAF acetylhydrolase enzyme<\/strong> could be developed into a drug<\/strong> against allergic reactions. One way it could be used is after a patient comes in contact with an allergen.<\/p>\n It may also be possible to take the drug on an ongoing basis, preventing severe allergic reactions before they happen.<\/p>\n More research is required before a drug can be developed.<\/p>\nPAF Acetylhydrolase<\/h2>\n
\nExternal Links<\/h3>\n